摘要
目的:通过分析近年循证药学发展相关文献,了解国内循证药学的发展现状。方法:以"循证"和"药"为检索词,对1998-2012年的中国医院知识总库和维普数据库进行检索,对循证药学平均文献量、基金资助率、论文合作度、期刊发布特点、文献研究方向等指标进行分析。结果:循证药学平均文献量为4.9篇/年,基金资助率为13%,平均论文合作度为2.59,排前10位的期刊载文量达到全部载文的50%,循证药学研究方向涉及8个方向。结论:目前循证药学发展较快,但仍处于发展初始阶段。
Objective： To understand the development status of the evidence-based pharmacy in China through literature review and analysis. Methods： Data and information were retrieved from the China Hospital Knowledge Database and VIP Database during 1998-2012 through key word searching of ＂evidence-based＂ and ＂pharmacy＂. The indexes were analyzed such as the average amount of literature of evidence-based pharmacy , fund rate, degree of paper cooperation , literature features and research directions , etc. Results： About 4.9 articles were published annually in the literature of evidence-based pharmacy, the fund rate was 13% , and the degree of paper cooperation was 2.59. For the top 10 journals 50% of the whole papers were published and 8 directions were involved in the evidence-based pharmacy researches. Conclusion： The evidence-based pharmacy is developed fast but is still in the initial stage of development.
出处
《中国执业药师》
CAS
2013年第7期35-37,共3页
China Licensed Pharmacist
关键词
循证药学
文献分析
医院药学
Evidence-based Pharmacy
Literature Analysis
Hospital Pharmacy
